Jakob Benedict Seidelin

Jakob Benedict Seidelin

Clinical Professor

Member of:

  • Internal Medicine: Gastroenterology and Hepatology


  1. 2021
  2. Published

    IBD metabonomics predicts phenotype, disease course, and treatment response

    Bjerrum, Jakob Tveiten , Wang, Y. L., Seidelin, Jakob Benedict & Nielsen, Ole Haagen, 2021, In: EBioMedicine. 71, 103551.

    Research output: Contribution to journalReviewResearchpeer-review

  3. Published

    Prevalence and outcomes of COVID-19 among patients with inflammatory bowel disease: A Danish prospective population-based cohort study

    Attauabi, M., Poulsen, A., Theede, K., Pedersen, N., Larsen, L., Jess, T., Rosager Hansen, M., Kajbæk Verner-Andersen, M., V Haderslev, K., Berg Lødrup, A., Molazahi, A., Neumann, A., Wase, A., Seidelin, Jakob Benedict & Burisch, J., 2021, In: Journal of Crohn's and Colitis. 15, 4, p. 540–550

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Short and long-term effectiveness and safety of vedolizumab in treatment-refractory patients with ulcerative colitis and Crohn's disease - a real-world two-center cohort study

    Attauabi, M., Vind, Ida, Pedersen, G., Bendtsen, Flemming, Seidelin, Jakob Benedict & Burisch, J., 2021, In: European journal of gastroenterology & hepatology. 33, 15, p. 709-718

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    The Incidence and Disease Course of Perianal Crohn's Disease: A Danish Nationwide Cohort Study, 1997-2015

    Wewer, M. D., Zhao, M., Nordholm-Carstensen, A., Weimers, P., Seidelin, Jakob Benedict & Burisch, J., 2021, In: Journal of Crohn's and Colitis (JCC). 15, 1, p. 5-13

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Vedolizumab as first-line biological therapy in elderly patients and those with contraindications for anti-TNF therapy: a real-world, nationwide cohort of patients with inflammatory bowel diseases

    Attauabi, M., Höglund, C., Fassov, J., Pedersen, K. B., Hansen, H. B., Wildt, S., Jensen, M. D., Neumann, A., Lind, C., Jacobsen, H. A., Popa, A. M., Kjeldsen, J., Pedersen, N., Molazahi, A., Haderslev, K., Aalykke, C., Knudsen, T., Cebula, W., Munkholm, P., Bendtsen, F. & 2 others, Seidelin, Jakob Benedict & Burisch, J., 2021, In: Scandinavian Journal of Gastroenterology. 56, 9, p. 1040-1048

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. 2020
  8. Published

    A fully defined 3D matrix for ex vivo expansion of human colonic organoids from biopsy tissue

    Bergenheim, F., Fregni, G., Buchanan, C. F., Riis, Lene Buhl, Heulot, M., Touati, J., Seidelin, Jakob Benedict, Rizzi, S. C. & Nielsen, Ole Haagen, 2020, In: Biomaterials. 262, 11 p., 120248.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Crohn's disease with progressive renal impairment

    Seidelin, Jakob Benedict, Riis, Lene Buhl & Butt, Rizwan Ahmed, 2020, In: Gastroenterology. 158, 1, p. 58-59 2 p.

    Research output: Contribution to journalComment/debateResearchpeer-review

  10. Published

    Predictors of response and disease course in patients with inflammatory bowel disease treated with biological therapy - The Danish IBD Biobank Project: protocol for a multicentre prospective cohort study

    Zhao, M., Bendtsen, Flemming, Petersen, Andreas Munk, Larsen, L., Dige, A., Hvas, C., Seidelin, Jakob Benedict & Burisch, J., 2020, In: BMJ Open. 10, 2, 7 p., e035756.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    SMAC mimetics and RIPK inhibitors as therapeutics for chronic inflammatory diseases

    Jensen, S., Seidelin, Jakob Benedict, LaCasse, E. C. & Nielsen, Ole Haagen, 2020, In: Science Signaling. 13, 619, 18 p., eaax8295.

    Research output: Contribution to journalReviewResearchpeer-review

  12. 2019
  13. Published

    Exposome and Diet

    Seidelin, Jakob Benedict & Burisch, J., 2019, Biomarkers in Inflammatory Bowel Diseases. Sheng Ding, N. & De Cruz, P. (eds.). Springer, p. 281-291 Chapter 23

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearchpeer-review

Previous 1 2 3 4 5 6 7 8 ...12 Next

ID: 33971112